Sign in to view content

Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO

Nikhil K Bommakanti, MD

Video
Published 2024

Related

Progression to Pars Plana Vitrectomy After Monotherapy With Panretinal Photocoagulation or Anti-VEGF injections in Proliferative Diabetic Retinopathy
Karen M Wai, MD
Annual Meeting Talks
2023
Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes
Jeffrey G. Gross, MD, FASRS
Updates from the Field
2018
Ranibizumab Induces Regression of Diabetic Retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2016

Category: AMD-Neovascular

See more